• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MRT68921 HCl

CAS No. 2070014-87-6

MRT68921 HCl ( —— )

产品货号. M20090 CAS No. 2070014-87-6

MRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM respectively).

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥486 有现货
10MG ¥770 有现货
25MG ¥1604 有现货
50MG ¥2900 有现货
100MG ¥3613 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    MRT68921 HCl
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM respectively).
  • 产品描述
    MRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM respectively).
  • 同义词
    ——
  • 通路
    Autophagy
  • 靶点
    Autophagy
  • 受体
    ULK1; ULK2
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2070014-87-6
  • 分子量
    471.04
  • 分子式
    C25H34N6O·HCl
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: 10 mg/mL;Water: 10 mg/mL
  • SMILES
    Cl.CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc2C1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Petherick KJ et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015 May 1;290(18):11376-83.
产品手册
关联产品
  • Lys05

    Lys05 (Lys01 trihydrochloride, PS-1001)is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay.

  • Sulfamethizole

    Sulfamethizole is a sulfathiazole antibacterial agent.

  • LYN-1604 2HCl 221675...

    LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.LYN-1604, to be the best candidate for a ULK1 agonist.LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.